KBC Group
ONC icon

KBC Group’s BeOne Medicines Ltd ONC Stock Holding History

KBC Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$372K Sell
1,016
-4,155
-80% -$1.42M ﹤0.01% 833
2026
Q2 		$1.47M Sell
5,171
-4,317
-45% -$1.27M ﹤0.01% 703
2026
Q1 		$2.82M Buy
9,488
+502
+6% +$162K 0.01% 595
2025
Q4 		$2.73M Hold
8,986
– – 0.01% 561
2025
Q3 		$3.06M Hold
8,986
– – 0.01% 520
2025
Q2 		$2.18M Buy
8,986
+49
+0.5% +$12K 0.01% 568
2025
Q1 		$2.43M Hold
8,937
– – 0.01% 561
2024
Q4 		$1.65M Hold
8,937
– – ﹤0.01% 720
2024
Q3 		$2.01M Hold
8,937
– – 0.01% 616
2024
Q2 		$1.28M Hold
8,937
– – ﹤0.01% 641
2024
Q1 		$1.4M Hold
8,937
– – ﹤0.01% 632
2023
Q4 		$1.61M Hold
8,937
– – 0.01% 636
2023
Q3 		$1.61M Sell
8,937
-2,412
-21% -$477K 0.01% 620
2023
Q2 		$2.02M Hold
11,349
– – 0.01% 602
2023
Q1 		$2.45M Hold
11,349
– – 0.01% 615
2022
Q4 		$2.5M Sell
11,349
-2,073
-15% -$380K 0.01% 566
2022
Q3 		$1.81M Sell
13,422
-1,101
-8% -$189K 0.01% 563
2022
Q2 		$2.35M Buy
14,523
+331
+2% +$51.7K 0.01% 515
2022
Q1 		$2.68M Buy
14,192
+125
+0.9% +$26.6K 0.01% 525
2021
Q4 		$3.81M Buy
14,067
+8,720
+163% +$2.94M 0.01% 499
2021
Q3 		$1.94M Sell
5,347
-13
-0.2% -$4.25K 0.01% 664
2021
Q2 		$1.84M Sell
5,360
-246
-4% -$81.5K 0.01% 682
2021
Q1 		$1.95M Sell
5,606
-1,148
-17% -$380K 0.01% 650
2020
Q4 		$1.74M Buy
6,754
+2,321
+52% +$639K 0.01% 669
2020
Q3 		$1.27M Buy
4,433
+282
+7% +$66.3K 0.01% 670
2020
Q2 		$782K Sell
4,151
-1,943
-32% -$316K 0.01% 738
2020
Q1 		$750K Buy
6,094
+130
+2% +$20.3K 0.01% 763
2019
Q4 		$989K Buy
5,964
+2,566
+76% +$426K 0.01% 901
2019
Q3 		$416K Hold
3,398
– – ﹤0.01% 1129
2019
Q2 		$421K Hold
3,398
– – ﹤0.01% 1108
2019
Q1 		$449K Buy
3,398
+776
+30% +$105K ﹤0.01% 1109
2018
Q4 		$368K Buy
+2,622
New +$348K ﹤0.01% 1000

Other funds holding ONC

Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $73.6B AUM 18.65% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

KBC Group's ONC Position: Q3 2026 in Review

KBC Group reduced its BeOne Medicines Ltd (ONC) stake by 80% in Q3 2026, selling an estimated $1.42M and leaving 1,016 shares worth $372K. The position accounts for ﹤0.01% of the portfolio, ranked #833.

KBC Group first reported a position in ONC in Q4 2018 and has held it in 32 quarters since. The position peaked at $3.81M in Q4 2021. 260 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

  • KBC Group held 1,016 shares of BeOne Medicines Ltd worth $372K as of Q3 2026.
  • KBC Group sold 4,155 BeOne Medicines Ltd shares in Q3 2026, an estimated $1.42M.
  • BeOne Medicines Ltd made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #833 holding.
  • KBC Group first reported a position in BeOne Medicines Ltd in Q4 2018 and has held it in 32 quarters since.
  • KBC Group's BeOne Medicines Ltd position peaked at $3.81M in Q4 2021.
  • 260 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.